This webinar series focuses on key challenges facing companies in the life sciences sector in the fields of competition law, EU and national regulation, data protection, and anti-corruption.

This session will focus on the recent fines imposed by competition authorities in the UK and Italy on pharmaceutical companies found to have charged excessive and unfair prices. In addition to the competition law issues raised, we will explore the relationship between competition law and national pharmaceutical pricing regulation.